Safety monitoring
Safety monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution.
Responsibility for data and safety monitoring depends on the phase of the study and may be conducted by sponsor or Contract research organization (CRO) staff or contractor, and/or by the Principal clinical investigator/project manager conducting the study. Regardless of the method used, monitoring must be performed on a regular basis. Oversight of the monitoring activity is the responsibility of the sponsor.
See also
- Clinical monitoring
- Data monitoring committee
- European Medicines Agency
- Serious adverse event (SAE)
- U.S. Food and Drug Administration (FDA)
References
- Ariel E. Quinio, Safety in Clinical Trials: Who is Responsible? International Biopharmaceutical Association:IBPA Publications, 2005
- Carol Rados, Inside Clinical Trials Testing Medical Products in People FDA Consumer magazine, September–October 2003 Issue
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.